Beatrice Bianchi, Author at WebNewsInsider

Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.
Beatrice Bianchi
Beatrice Bianchi covers world news and international conflict with a European eye, from Brussels policy fights to the wars on Europe’s borders. She brings a historian’s habit of checking today’s claims against the record.

Latest stories

September 18, 2025
Keytruda in Cancer Care: How Pembrolizumab Works and Which Side Effects to Watch
Patients receiving pembrolizumab, the immunotherapy drug sold as Keytruda, commonly report a range of side effects including fatigue, musculoskeletal pain, diarrhea, nausea,…
July 17, 2025
Takeda’s Oveporexton Meets All Endpoints in Two Phase 3 Narcolepsy Type 1 Trials
In July 2025, Takeda announced that its experimental wake‑promoting drug, oveporexton, successfully completed phase 3 clinical testing for narcolepsy. The trial results…
September 18, 2024
England’s Junior Doctors Accept 22% Pay Deal, Ending 18-Month NHS Dispute
United Kingdom, September 18, 2024 — cybernewschronicle.com — The 2022–2024 National Health Service (NHS) strikes were a series of concurrent industrial disputes…
July 10, 2024
Researchers Identify Lupus Root Cause, Potential Cure
Chicago, July 10, 2024 — infopulsetoday.com — For millions living with systemic lupus erythematosus, the disease has long felt like a life…
May 17, 2024
FDA Grants Accelerated Approval to Imdelltra for Extensive-Stage Small Cell Lung Cancer
The U.S. Food and Drug Administration announced in May 2024 that it has approved Tarlatamab, marketed as Imdelltra, for the treatment of…
February 29, 2024
North Korean Spy Satellite Performs First Orbital Maneuver
For months, South Korea’s defense ministry had a clear story: North Korea’s first spy satellite was dead in orbit. A piece of…
December 17, 2023
CRISPR Therapeutics Holds the First Approved CRISPR Therapy, but Its Stock Is Stuck
On December 15, 2023, the biotechnology industry is abuzz with the recent regulatory approval of a groundbreaking treatment by CRISPR Therapeutics AG,…
December 7, 2023
Bahrain Approves DNA-Rewriting Therapy Casgevy
Manama, Bahrain, December 7, 2023 — infopulsetoday.com — MANAMA, Bahrain — The approval came quietly, in a regulatory filing on a Saturday.…
December 6, 2023
Mali Reports 21 Dengue Deaths and 600 Cases, Health Director Says
Health officials in Mali announced that, by early December 2023, the country had documented 600 confirmed cases of dengue fever and at…
November 15, 2023
AbbVie to Acquire ImmunoGen for $10.1 Billion, Adding Ovarian Cancer Drug Elahere
On a Wednesday in mid-November, AbbVie decided it would pay $10.1 billion for ImmunoGen. That is a lot of money for a…
May 22, 2023
NHS Rolls Out Glofitamab for Aggressive Lymphoma After Just One Prior Treatment
Diffuse large B‑cell lymphoma progresses rapidly and can infiltrate lymph nodes, spleen, liver, and bone marrow. For many patients whose disease returns…
April 20, 2023
Federal Registry Tracks Firefighter Cancer to Find Prevention Methods Nationwide
For decades, firefighters have faced a grim reality: the very substances they encounter while battling blazes can trigger cancer years later. Benzene,…
May 16, 2022
FDA Approves Lilly’s Mounjaro, a Once-Weekly Dual-Action Drug for Type 2 Diabetes
Millions of Americans who live with type 2 diabetes now have an additional medication to consider. Tir tirzepatide, cleared by the U.S.…
June 1, 2021
Study Reveals Varied Effectiveness of Cloth Masks in Blocking Droplets
Researchers at Florida Atlantic University measured how far simulated cough droplets moved when different face coverings were used. The experiment, led by…
February 12, 2020
Coronavirus Deaths in Mainland China Rise to 811, Passing the SARS Toll
The novel coronavirus outbreak now sits on a grimmer part of history. The death toll inside mainland China has passed the final…